Theranostics: The future of nuclear medicine

Speaker: 
Steven Larson (Memorial Sloan Kettering Cancer Center)
Event Date and Time: 
Wed, 2016-05-04 14:00 - 15:00
Location: 
TRIUMF Auditorium


Theranostics is the use of the same molecular moiety for a combination of diagnosis and therapy. Radiotracers lend themselves to theranostics, because it is simply a matter of scaling up the dose, from diagnosis to therapy, in some important instances. A case in point would be the use of 124I for quantitative imaging, staging and diagnosis, in a patient who will subsequently be treated with 131I, for thyroid cancer. Other examples include the use of radiolabeled antibodies such as 124I-3F8 (an anti-GD2, antigen) at a low level for diagnosis, and then scaling up for therapeutic effect. PET imaging, and in some intstaces quantiative SPECT imaging, are the normal diagnostic imaging agents employed.

Website development by Checkmark Media. Designed by Armada.

a place of mind, The University of British Columbia

Faculty of Science
Department of Physics and Astronomy
6224 Agricultural Road
Vancouver, BC V6T 1Z1
Tel 604.822.3853
Fax 604.822.5324

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia